No Image Available

RF ablation systems

Barrx™ radiofrequency ablation system

<p>The Barrx™ radiofrequency ablation system includes the Barrx™ flex RFA energy generator and a family of ablation catheters which are designed to precisely control depth and uniformity of GI tissue ablation.</p>

Features



Explore the Barrx™ radiofrequency ablation system components

Barrx™ flex RFA energy generator

Barrx™ flex RFA energy generator

The Barrx™ flex RFA energy generator is a bipolar radiofrequency generator that provides the flexibility to choose either the Barrx™ 360 express RFA balloon catheter for larger treatment areas or Barrx™ RFA focal catheters for smaller focal areas.

Barrx™ 360 express RFA balloon catheter

Barrx™ 360 express RFA balloon catheter

The Barrx™ 360 express RFA balloon catheter features a self-adjusting ablation balloon that eliminates the sizing process.

PillCam™ SB 3 sensor belt

Barrx™ RFA focal catheters

The Barrx™ RFA focal catheter enables physicians to provide primary treatment for short and intermediate length segments of non-circumferential Barrett's esophagus or provide secondary treatment after ablation with the Barrx™ 360 RFA balloon catheter (or other therapeutic devices).

Barrx™ channel RFA endoscopic catheter

Barrx™ channel RFA endoscopic catheter

The Barrx™ channel RFA endoscopic catheter delivers radiofrequency ablation after being placed through the working channel of a flexible endoscope.

Barrx™ RFA accessories

Barrx™ RFA accessories

Barrx™ accessories include endoscopic guidewires, cleaning caps, and a cart to hold ablation equipment.

Ordering information

Item number Description Units per box
1190A-115A Barrx™ Flex RFA Energy Generator, 115V.
Contains 1 Barrx™ flex RFA footswitch and 1 Barrx™ flex RFA output cable included with each generator.
1
1190A-230A Barrx™ flex RFA energy generator, 230V. Contains 1 Barrx™ flex RFA footswitch and 1 Barrx™ flex RFA output cable included with each generator.
1
FLEXFS-010A Barrx™ flex RFA footswitch, 10' (3 m) 1
FLEXCC-020A Barrx™ flex RFA output cable, 9' (2.7 m) 1

Related links

Capsule Endoscopy System Tech Support Promo Box

Technical support

Get technical support for all endoscopy products.

Email us
Phone UK & IE
: +44 1923 201860

† 94% is the calculated relative risk reduction [(26-1.5)/26] = 25/26 100. From [25.0% (1.5% for ablation versus 26.5% for control; 95%CI, 14.1%–35.9%; P < .001].

  1. Fleischer DE, Overholt BF, Sharma VK, et al. Endoscopic radiofrequency ablation for Barrett's esophagus: 5-year outcomes from a prospective multicenter trial. Endoscopy. 2010;42(10):781–789
  2. American Cancer Society. Key statistics for esophageal cancer. Last revised January 2023. Accessed April 2023.
  3. ESGE Guideline 2023. Page 5/5 screening & case finding.
  4. Phoa KN, van Vilsteren FG, Pouw RE, et al. Radiofrequency ablation versus endoscopic surveillance for patients with Barett esophagus and low-grade dysplasia: a randomized clinical trial. JAMA. 2014;311(12):1209–1217.
  5. Shaheen NJ, Sharma P, Overholt BF, et al. Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med. 2009;360(22):2277–2288.
  6. Wolf WA, Pasricha S, Cotton C, et al. Incidence of esophageal adenocarcinoma and causes of mortality after radiofrequency ablation of Barrett’s esophagus. Gastroenterology. 2015;149(7):1752–1761.
  7. Sharma P, Shaheen N, Katzka D, Bergman JGHM. AGA clinical practice update on endoscopic treatment of Barrett's esophagus with dysplasia and/or early cancer: expert review. Gastroenterology. 2020;158(3):760–769.
  8. Shaheen NJ, Falk GW, Iyer PG, Gerson, LB. ACG clinical guideline: diagnosis and management of Barrett’s esophagus. Am J Gastroenterol. 2016;111(1):30–50.